Urografin 76% Injection

Product Details

Urografin Ampule 76% Injection is a radiopaque contrast medium used in diagnostic imaging, particularly in procedures such as urography, intravenous pyelography, and other radiological examinations of the urinary tract. The active ingredient in Urografin is iopamidol, which enhances the visibility of internal structures by absorbing X-rays. This allows for clearer imaging of the kidneys, ureters, and bladder, facilitating accurate diagnosis and assessment of various urinary tract conditions.

Uses:

• Urography (X-ray examination of the urinary tract)
• Intravenous pyelography (IVP)
• Imaging of kidney stones or tumors
• Evaluation of urinary tract obstruction
• Assessment of renal function and abnormalities

Side Effects:

• Common side effects: nausea, vomiting, warmth or flushing, and metallic taste.
• Serious side effects: allergic reactions (including anaphylaxis), kidney dysfunction, and contrast-induced nephropathy; immediate medical attention is required if symptoms such as difficulty breathing or swelling occur.

Key Features:

• Contains iopamidol, a non-ionic, water-soluble contrast agent.
• Provides high contrast and low viscosity for easier injection and improved imaging.
• Used in a variety of diagnostic imaging procedures for effective assessment of the urinary tract.
• Generally well-tolerated, with a low incidence of severe adverse reactions.

FAQ:

1. How does Urografin 76% Injection work?
   Urografin absorbs X-rays, which enhances the visibility of the urinary tract on imaging studies, allowing healthcare providers to better diagnose and assess conditions.
2. What should I inform my doctor before receiving Urografin?
   Inform your doctor about any allergies (especially to iodine or contrast agents), kidney problems, and any medications you are currently taking.
3. What precautions should I take after receiving Urografin?
   Drink plenty of fluids to help flush the contrast from your system, and report any unusual symptoms, such as difficulty breathing or rash, to your healthcare provider immediately.

References:

1. Bayer HealthCare Pharmaceuticals. “Urografin 76% Injection.” U.S. Food and Drug Administration. [Accessed on 5 Nov 2024]. Available from: https://www.medicines.org.uk/emc/product/2982/pil
2. European Medicines Agency (EMA). “Urografin (iopamidol) Product Information.” [Accessed on 5 Nov 2024]. Available from: https://www.bayer.com/sites/default/files/UROGRAFIN_60_76_EN_PI.pdf